Bone elongation in rats with renal failure and mild or advanced secondary hyperparathyroidism

Kidney International

Volumn 65, Issue 5, 2004, Pages 1740-1748

  Sanchez, Cheryl P ^a   He, Yu Zhu ^b   Leiferman, Ellen ^b   Wilsman, Norman J ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b NONE

Author keywords

Endochondral bone formation; Growth plate; Secondary hyperparathyroidism

Indexed keywords

CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; SOMATOMEDIN BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CALCIUM BLOOD LEVEL; CARTILAGE CELL; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; GENETIC TRANSCRIPTION; HYPERTHYROIDISM; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY FAILURE; LEG LENGTHENING; MALE; MINERALIZATION; MORPHOMETRICS; NEPHRECTOMY; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STANDARDIZATION; WEIGHT GAIN;

EID: 2342616157     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00577.x     Document Type: Conference Paper

References (35)

1. COBO A, LOPEZ JM, CARBAJO E, et al: Growth plate cartilage formation and resorption are differentially expressed in growth retarded uremic rats. J Am Soc Nephrol 10:971-979, 1999
2. SANCHEZ CP, SALUSKY IB, KUIZON BD, et al: Growth of long bones in renal failure: Roles of hyperparathyroidism, growth hormone and calcitriol. Kidney Int 54:1879-1887, 1998
3. URENA P, FERREIRA A, MORIEUX C, et al: PTH/PTHrP receptor mRNA is down-regulated in epiphyseal cartilage growth plate of uremic rats. Nephrol Dial Transplant 11:2008-2016, 1996
4. HANNA JD, SANTOS F, FOREMAN JW, et al: Insulin-like growth factor-I gene expression in the tibial epiphyseal growth plate of growth hormone-treated uremic rats. Kidney Int 47:1374-1382, 1995
5. MEHLS O, RITZ E, GILLI G, et al: Skeletal changes and growth in experimental uremia. Nephron 18:288-300, 1977
6. ALVAREZ J, BALBIN M, FERNANDEZ M, et al: Collagen metabolism is markedly altered in the hypertrophic cartilage of growth plates from rats with growth impairment secondary to chronic renal failure. J Bone Miner Res 16:511-524, 2001
7. BREUR GJ, VANENKEVORT BA, FARNUM CE, et al: Linear relationship between the volume of hypertrophic chondrocytes and the rate of longitudinal bone growth in growth plates. J Orthop Res 9:348-359, 1991
8. WILSMAN NJ, FARNUM CE, LEIFERMAN EM, et al: Differential growth by growth plates as a function of multiple parameters of chondrocytic kinetics. J Orthop Res 14:927-936, 1996
9. HUNZIKER EB: Mechanism of longitudinal bone growth and its regulation by growth plate chondrocytes. Microsc Res Techniq 28:505-519, 1994
10. LEE K, DEEDS JD, BOND AT, et al: In situ localization of PTH/PTHrP receptor mRNA in the bone of fetal and young rats. Bone 14:341-345, 1993
11. SANCHEZ CP, HE Y-Z: Alterations in the growth plate cartilage of rats with renal failure receiving corticosteroid therapy. Bone 30:692-698, 2002
12. SANCHEZ CP, HE Y-Z: Effects of thyroparathyroidectomy, exogenous calcium, and short-term calcitriol therapy on the growth plate in renal failure. J Am Soc Nephrol 14:148-158, 2003
13. TONSHOFF B, POWELL DR, ZHAO D, et al: Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and -2 gene expression in experimental uremia. Endocrinology 128:938-946, 1997
14. BLUM WF, RANKE MB, KIETZMANN K, et al: Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uremia. Pediatr Nephrol 5: 539-544, 1991
15. WANG J, ZHOU J, BONDY CA: IGF-I promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy. FASEB J 13:1985-1990, 1999
16. FINE RN, ATTIE KM, KUNTZE J, et al: Recombinant human growth hormone in infants and young children with chronic renal insufficiency. Pediatr Nephrol 9:451-457, 1995
17. KOVACS GT, OH J, KOVACS J, et al: Growth promoting effects of growth hormone and IGF-I are additive in experimental uremia. Kidney Int 49:1413-1421, 1996
18. WUHL E, HAFFNER D, NISSEL R, et al: Short dialyzed children respond less to growth hormone than patients prior to dialysis. Pediatr Nephrol 10:294-298, 1996
19. VORTKAMP A, LEE K, LANKSE B, et al: Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273:613-622, 1996
20. LANSKE B, KARAPLIS AC, LEE K, et al: PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273:663-666, 1996
21. LANSKE B, AMLING M, NEFF L, et al: Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J Clin Invest 104:399-407, 1999
22. AMIZUKA N, WARSHAWSKY H, HENDERSON JE, et al: Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J Cell Biol 126:1611-1623, 1994
23. CHUNG U-I, SCHIPANI E, MCMAHON AP, et al: Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development. J Clin Invest 107:295-304, 2001
24. KOBAYASHI T, CHUNG U-I, SCHIPANI E, et al: PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps. Development 129:2977-2986, 2002
25. FARQUHARSON C, JEFFERIES D, SEAWRIGHT E, et al: Regulation of chondrocyte terminal differentiation in the postembryonic growth plate: The role of the PTHrP-Indian hedgehog axis. Endocrinology 142:4131-4140, 2001
26. HARVEY AK, YU X-P, FROLIK CA, et al: Parathyroid hormone-(1-34) enhances aggrecan synthesis via an insulin-like growth factor-I pathway. J Biol Chem 274:23249-23255, 1999
27. DIVIETI P, JOHN MR, JUPPNER H, et al: Human PTH-(7-84) inhibits bone resorption in vitro actions independent of the type 1 PTH/PThrP receptor. Endocrinology 143:171-176, 2002
28. LANGUB MC, MONIER-FAUGERE M-C, WANG G, et al: Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure. Endocrinology 144:1135-1138, 2003
29. BIKLE DD, SAKATA T, LEARY C, et al: Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. J Bone Miner Res 17:1570-1578, 2002
30. KIEPE D, ANDRESS DL, MOHAN S, et al: Intact IGF-binding protein-4 and -5 and their respective fragments isolated from chronic renal failure serum differentially modulate IGF-I actions in cultured growth plate chondrocytes. J Am Soc Nephrol 12:2400-2410, 2001
31. FINE RN, KOHAUT EC, BROWN D, et al: Growth after recombinant human growth hormone treatment in children with chronic renal failure: Report of a multicenter randomized double-blind placebo-controlled study. J Pediatr 94:374-382, 1994
32. 3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. Endocrinology 129:3139-3146, 1991
33. 3 on cartilage growth in neonatal mice. Metab Bone Dis Rel Res 4:337-345, 1983
34. PANCZYK-TOMASZEWSKA M, ZIOLKOWSKA H, DEBINSKI A, et al: Vitamin D metabolite requirements in dialysed children receiving recombinant human growth hormone. Nephrol Dial Transplant 15:375-378, 2000
35. BACKELJAUW PF, UNDERWOOD LE: Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: A clinical research center study. J Clin Endocrinol Metab 86:1504-1503, 2001